These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7945429)

  • 1. Effects of extracellular divalent cations on responses of human blood platelets to adenosine 5'-diphosphate.
    Hall DA; Frost V; Hourani SM
    Biochem Pharmacol; 1994 Oct; 48(7):1319-26. PubMed ID: 7945429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine 5-diphosphate antagonists and human platelets: no evidence that aggregation and inhibition of stimulated adenylate cyclase are mediated by different receptors.
    Cusack NJ; Hourani SM
    Br J Pharmacol; 1982 May; 76(1):221-7. PubMed ID: 6282375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of suramin on increases in cytosolic calcium and on inhibition of adenylate cyclase induced by adenosine 5'-diphosphate in human platelets.
    Hall DA; Hourani SM
    Biochem Pharmacol; 1994 Mar; 47(6):1013-8. PubMed ID: 8147900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of analogues of adenine nucleotides on increases in intracellular calcium mediated by P2T-purinoceptors on human blood platelets.
    Hall DA; Hourani SM
    Br J Pharmacol; 1993 Mar; 108(3):728-33. PubMed ID: 8467360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effects of ATP on platelet aggregation: cation interaction and shape change.
    Wang TY; Hussey CV; Garancis JC
    Ann Clin Lab Sci; 1977; 7(1):88-92. PubMed ID: 836006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benzoyl ATP is an antagonist of rat and human P2Y1 receptors and of platelet aggregation.
    Vigne P; Hechler B; Gachet C; Breittmayer JP; Frelin C
    Biochem Biophys Res Commun; 1999 Mar; 256(1):94-7. PubMed ID: 10066429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of adenine nucleotide analogues on shape change and aggregation induced by adnosine 5-diphosphate (ADP) in human platelets.
    Park HS; Hourani SM
    Br J Pharmacol; 1999 Jul; 127(6):1359-66. PubMed ID: 10455285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Competitive inhibition by adenosine 5'-triphosphate of the actions on human platelets of 2-chloroadenosine 5'-diphosphate, 2-azidoadenosine 5'-diphosphate and 2-methylthioadenosine 5'-diphosphate.
    Cusack NJ; Hourani SM
    Br J Pharmacol; 1982 Oct; 77(2):329-33. PubMed ID: 7139191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors influencing the response of human blood platelets to analogues of ADP which may act as partial agonists at the ADP receptor.
    Egan CM; Fisher AP; Scrutton MC
    Eur J Biochem; 1979 Mar; 95(1):127-37. PubMed ID: 110586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial agonist behaviour of adenosine 5'-O-(2-thiodiphosphate) on human platelets.
    Cusack NJ; Hourani SM
    Br J Pharmacol; 1981 Jun; 73(2):405-8. PubMed ID: 7236992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of calcium, thrombin and nucleotides (ADP, cAMP, cGMP) on blood platelet glycolysis and energy metabolism].
    Nikulin AA
    Farmakol Toksikol; 1980; 43(5):585-90. PubMed ID: 6256208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of antimycin and 2-deoxyglucose on adenine nucleotides in human platelets. Role of metabolic adenosine triphosphate in primary aggregation, secondary aggregation and shape change of platetets.
    Holmsen H; Setkowsky CA; Day HJ
    Biochem J; 1974 Nov; 144(2):385-96. PubMed ID: 4462589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of divalent cations on the potency of ATP and related agonists in the rat isolated vagus nerve: implications for P2 purinoceptor classification.
    Trezise DJ; Bell NJ; Kennedy I; Humphrey PP
    Br J Pharmacol; 1994 Oct; 113(2):463-70. PubMed ID: 7834197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the P2-purinoceptor antagonist, suramin, on human platelet aggregation induced by adenosine 5'-diphosphate.
    Hourani SM; Hall DA; Nieman CJ
    Br J Pharmacol; 1992 Feb; 105(2):453-7. PubMed ID: 1559134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of ADP-induced responses in human platelets by agents elevating the cyclic AMP level: comparison of aggregation and shape change.
    Steen VM; Holmsen H
    Thromb Haemost; 1984 Dec; 52(3):333-5. PubMed ID: 6099615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Responses to adenosine diphosphate in human platelets loaded with the fluorescent calcium indicator quin2.
    Hallam TJ; Rink TJ
    J Physiol; 1985 Nov; 368():131-46. PubMed ID: 4078739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandin E1 potentiates the effects of P2Y12 blockade on ADP-mediated platelet aggregation in vitro: Insights using short thromboelastography.
    Khanna V; Armstrong PC; Warner TD; Curzen N
    Platelets; 2015; 26(7):689-92. PubMed ID: 25734957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of ADP-induced platelet aggregation by adenosine tetraphosphate.
    Harrison MJ; Brossmer R
    Thromb Haemost; 1976 Nov; 36(2):388-91. PubMed ID: 1036839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two mechanisms for inhibition of ADP-induced platelet shape change by 5'-p-fluorosulfonylbenzoyladenosine. Conversion to adenosine, and covalent modification at an ADP binding site distinct from that which inhibits adenylate cyclase.
    Mills DC; Figures WR; Scearce LM; Stewart GJ; Colman RF; Colman RW
    J Biol Chem; 1985 Jul; 260(13):8078-83. PubMed ID: 2989276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of RP and SP diastereoisomers of adenosine 5'-O-(1-thiodiphosphate) on human platelets.
    Cusack NJ; Hourani SM
    Br J Pharmacol; 1981 Jun; 73(2):409-12. PubMed ID: 7236993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.